chrX-80443626-A-C
Variant summary
The NM_152630.5(TENT5D):c.1087A>C(p.Ile363Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000182 in 1,096,814 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I363T) has been classified as Likely benign.
Frequency
Consequence
NM_152630.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_152630.5. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TENT5D | TSL:1 MANE Select | c.1087A>C | p.Ile363Leu | missense | Exon 3 of 3 | ENSP00000308575.5 | Q8NEK8 | ||
| TENT5D | TSL:2 | c.1087A>C | p.Ile363Leu | missense | Exon 5 of 5 | ENSP00000443410.1 | Q8NEK8 | ||
| TENT5D | c.1087A>C | p.Ile363Leu | missense | Exon 4 of 4 | ENSP00000597423.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome AF: 0.00000182 AC: 2AN: 1096814Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 362582 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome Cov.: 23
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.